Clinical Justification for iNO Therapy: Evidence, Patient Selection, and Reassessment
A defensible clinical justification for iNO therapy links an infant’s physiology, optimized ventilation and a measurable treatment goal. The Canadian…
Benefits of Generator-Based iNO: Clinical and Operational Considerations
What if inhaled nitric oxide availability depended less on cylinder delivery and replacement? The benefits of generator-based iNO may include a…
A Comprehensive Guide to Switching from INOmax Cylinders
Canadian hospitals switching from legacy INOmax gas cylinders can move to cylinderless point-of-care generators or retain carefully specified…
Alternatives to Cylinder-Based Nitric Oxide: The Future of Canadian iNO Delivery
What if your hospital’s supply of inhaled nitric oxide was as reliable and accessible as the ambient air in your clinical environment? For years,…
Procuring Respiratory Therapy Equipment in Canada: A Clinical Buyer’s Guide
Relying on traditional procurement models is no longer enough to safeguard the stability of a Canadian ICU. You’ve likely felt the strain of…
Inhaled Nitric Oxide Cost Guide for Canadian Hospitals
What if the most expensive component of your inhaled nitric oxide therapy isn’t the gas itself, but the heavy steel cylinders used to transport it?…
Nitric Oxide Supply Chain Alternatives: Moving Beyond Medical Gas Cylinders
The most resilient supply chain for inhaled nitric oxide (iNO) is the one that doesn’t exist at all. For years, Canadian clinical teams have balanced…